| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |